Jane Street
RGNT

Jane Street’s Regentis Biomaterials RGNT Stock Holding History

Jane Street’s Portfolio RGNT Stock Details RGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Buy
+43,333
New +$124K ﹤0.01% 10333

Other funds holding RGNT

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Jane Street's RGNT Position: Q2 2026 in Review

Jane Street opened a new position in Regentis Biomaterials (RGNT) in Q2 2026: 43,333 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #10333 among its holdings.

6 funds tracked by Wall St. Rank hold RGNT as of Q2 2026.

  • Jane Street held 43,333 shares of Regentis Biomaterials worth $153K as of Q2 2026.
  • Regentis Biomaterials was a new Jane Street position in Q2 2026.
  • Regentis Biomaterials made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10333 holding.
  • 6 funds tracked by Wall St. Rank held Regentis Biomaterials as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.